With over 25 years' experience in the In-Vitro Diagnostics (IVD) industry, starting as a clinical site coordinator, to moving on to product support and finally establishing her career in clinical study management for the past 16 years, Dr. Martel brings her vast knowledge of clinical development and operations to MCRA. Her leadership in managing multisite clinical teams has led to many successful regulatory approvals worldwide in various diagnostic areas; cardiac, infectious disease, diabetes, and autoimmune to name a few. Most products launched globally.
Dr. Martel received her Bachelor, Master and PhD in Biochemistry from the University of Sherbrooke, Quebec, Canada.
Prior to MCRA, Dr. Martel Spent over 20 years at Siemens Healthcare Diagnostics. Her last position was as the Senior Director if Clinical Affairs, where she gained most of her experience in the IVD arena. She has also gained knowledge in urine chemistry, hematology as well as IVD in point of care.
Dr. Martel more recently was the Global Head of Clinical Operations and Development for Ascensia Diabetes Care, where she led a clinical team supporting global clinical studies for glucose meters and continuous glucose monitoring (CGM) devices. She also played an important role in process improvement to remain within compliance of the new European regulations (MDR and IVDR).
Dr. Martel has a wealth of IVD experience to support clinical design and execution for highly regulated products as well as novel area requiring new ways of approaching the study set up. She thrives on quality execution of the clinical studies by assisting with the day-to-day needs and keeping an open and clear communication channel with the clients on the project status.